Version 5.4
Mus musculus Protein: Lrit2
Summary
InnateDB Protein IDBP-151025.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Lrit2
Protein Name leucine-rich repeat, immunoglobulin-like and transmembrane domains 2
Synonyms
Species Mus musculus
Ensembl Protein ENSMUSP00000056642
InnateDB Gene IDBG-151023 (Lrit2)
Protein Structure
UniProt Annotation
Function
Subcellular Localization Membrane; Single-pass type I membrane protein.
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
GO:0003674 molecular_function
GO:0005515 protein binding
Biological Process
GO:0008150 biological_process
Cellular Component
GO:0005575 cellular_component
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID MGI:2444885
InterPro IPR000483 Cysteine-rich flanking region, C-terminal
IPR001611 Leucine-rich repeat
IPR003591 Leucine-rich repeat, typical subtype
IPR003598 Immunoglobulin subtype 2
IPR003599 Immunoglobulin subtype
IPR003961 Fibronectin, type III
IPR007110 Immunoglobulin-like domain
IPR013098 Immunoglobulin I-set
PFAM PF01463
PF00560
PF13504
PF13855
PF00041
PF01108
PF07679
PRINTS
PIRSF
SMART SM00082
SM00369
SM00408
SM00409
SM00060
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q6PFC5
PhosphoSite PhosphoSite-Q6PFC5
TrEMBL
UniProt Splice Variant
Entrez Gene 239038
UniGene Mm.134302
RefSeq NP_775594
MGI ID
MGI Symbol Lrit2
OMIM
CCDS CCDS26951
HPRD
IMGT
EMBL BC057628
GenPept AAH57628

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca